| 2011 |
| 11/15/2011 | Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
|
| 10/26/2011 | IntelligentMDx Presents the IMDx C. difficile for Abbott m2000 assay at the 46th Annual American Society for Microbiology Regional Meeting
|
| 10/25/2011 | George David joins Board of Directors at IMDx
|
| 9/21/2011 | IntelligentMDx (IMDx) Introduces a CE-Marked Automated Molecular Test for the Detection of Vancomycin Resistance Genes vanA and vanB Most Commonly Found in Vancomycin-Resistant Enterococci
|
| 8/24/2011 | IMDx Announces Issuance of a Key Personalized Medicine Patent Entitled “Devices and Methods for Diagnosis of Susceptibility to Diseases and Disorders"
|
| 8/1/2011 | Intelligent Medical Devices, Inc. (IMDx) Introduces a CE-Marked Automated Assay for the Detection of C. difficile Including Hypervirulent Strains.
|
| 6/28/2011 | IMDx stresses the need for earlier and more accurate detection of carriers of health care-associated infections (HAI).
|
| 5/31/2011 | Michelle Facktor, Founder and Managing Director of Renaissance Capital, Joins IMDx's Board of Directors
|
| 5/2/2011 | Richard Del Mastro, Ph.D. Named New Vice President, Research and Development
|
| 3/15/2011 | Biosearch Technologies and Intelligent Medical Devices, Inc. (IMDx) Finalize cGMP Oligo Supply and Licensing Agreements for Molecular Diagnostic Testing (IVD) Products.
|
| 1/20/2011 | Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu of Molecular Tests
|
| 1/17/2011 | Sarah Toomey, Esq. Promoted to Senior Director, Legal and Business Development
|